SCHEMBL1102677

SCHEMBL1102677

c1ccc(-c2c3ccccc3c(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccncc45)cc3)c3ccccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.47
NOTUM Q6P988 1/20 0.44
MAP2 P11137 1/20 0.44
KDM4E B2RXH2 3/20 0.42
ACHE P22303 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
IKBKB O14920 1/20 0.42
AURKA O14965 1/20 0.42
CHUK O15111 1/20 0.42
PIM1 P11309 1/20 0.42
TOP1 P11387 1/20 0.42
GABRA1 P14867 1/20 0.42
IDO1 P14902 1/20 0.42
HPGD P15428 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102798 1.00 TNF (0.47) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102806 1.00 TNF (0.47) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102900 1.00 TNF (0.47) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102643 0.98 NOTUM (0.48) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102793 0.98 NOTUM (0.48) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102483 0.98 NOTUM (0.48) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102728 0.98 NOTUM (0.48) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102490 0.98 TNF (0.48) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102751 0.93 TNF (0.54) TNFNOTUMMAP2KDM4EACHE
SCHEMBL1102863 0.91 ACHE (0.45) TNFMAP2KDM4EACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
EP-2147962-A1 Azaanthracene-derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TNF 3803/4885NOTUM 8/4885MAP2 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.